163-172
Original Paper
Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group
Karin Oechsle, Carsten Bokemeyer, Jörg T. Hartmann, Wilfried Budach and Tanja Trarbach, et al.
173-179
Original Paper
Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated IκB kinase
Ivana von Metzler, Holger Krebbel, Ulrike Kuckelkorn, Ulrike Heider and Christian Jakob, et al.
181-189
Original Paper
Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line
Yi-Xuan Yang, Xue-Feng Sun, Ai-Lan Cheng, Gui-Ying Zhang and Hong Yi, et al.
191-195
Original Paper
Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?
Gernot Hudelist, Pia Wuelfing, Klaus Czerwenka, Martin Knöfler and Sandra Haider, et al.
197-202
Original Paper
Laparoscopic radical cystectomy with orthotopic gastric neobladder: technique and initial outcomes
Xing-Huan Wang, Xiao-Yong Pu, Huai-Peng Wang and Li-Quan Hu
203-209
Original Paper
In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR
Nongnit Laytragoon-Lewin, Hasan Ustun, Juan Castro, Signe Friesland and Mehran Ghaderi, et al.
211-216
Original Paper
Nerve growth factor/nuclear factor-κB pathway as a therapeutic target in breast cancer
Ali Naderi and Luke Hughes-Davies
217-226
Original Paper
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401
Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, Antonio Farris and Donato Natale, et al.
227-234
Original Paper
Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro
M. Schmidt-Hieber, A. Busse, B. Reufi, W. Knauf and E. Thiel, et al.
235-240
Original Paper
Expression of Indian Hedgehog signaling molecules in breast cancer
Yanhua Xuan and Zhenhua Lin
241-247
Original Paper
Reduced expression of C/EBPα protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival
Hsi-Huang Tseng, Yaw-Huei Hwang, Kun-Tu Yeh, Jan-Gowth Chang and Yao-Li Chen, et al.
249-253
Original Paper
Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients
Hailiang Zhang, Dingwei Ye, Xudong Yao, Bo Dai and Shilin Zhang, et al.
255-264
Original Paper
Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients
Leticia Llanes-Fernández, Maria del Carmen Arango-Prado, Juan Manuel Alcocer-González, Marta Elena Guerra-Yi and Sonia Franco-Odio, et al.
265-270
Original Paper
Molecular characterization of the DYX1C1 gene and its application as a cancer biomarker
Yun-Ji Kim, Jae-Won Huh, Dae-Soo Kim, Min-In Bae and Ja-Rang Lee, et al.
271-281
Original Paper
Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer
G. Treiber, T. Wex and P. Malfertheiner
283-290
Original Paper
Open AccessSerum vascular endothelial growth factor: a prognostic factor in cervical cancer
Petra L. M. Zusterzeel, Paul N. Span, Marja G. K. Dijksterhuis, Chris M. G. Thomas and Fred C. G. J. Sweep, et al.
291-295
Original Paper
Study on the mutations in the D-loop region of mitochondrial DNA in cervical carcinoma
Daozhen Chen and Huiying Zhan
297-301
Original Paper
Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation
Min Soo Kim, Eun Hee Kook, Se Han Ahn, Se Young Jeon and Jung Ho Yoon, et al.
303-311
Original Paper
Loss of PTEN function may account for reduced proliferation pathway sensitivity to LY294002 in human prostate and bladder cancer cells
Shigeru Kanda, Hiroshi Kanetake and Yasuyoshi Miyata
313-318
Original Paper
EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer
Hidefumi Sasaki, Katsuhiro Okuda, Shigeki Shimizu, Minoru Takada and Masaaki Kawahara, et al.
319-323
Rapid Communication
Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
S. Chandramathi, K. Suresh, Z. B. Anita and U. R. Kuppusamy
325-326
Letter to the Editor
Control of aggressive fibromatosis by treatment with imatinib mesylate: a step forward?
Alberto Ravaioli, Stefania Nicoletti, Emiliano Tamburini and Maximilian Papi